Intraoperative Radiotherapy in Early-Stage Breast Cancer: Results of the Montpellier Phase II Trial

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 3, 2010, Pages 698-703

  Lemanski, Claire ^a   Azria, David ^a   Gourgon Bourgade, Sophie ^a   Gutowski, Marian ^a   Rouanet, Phillippe ^a   Saint Aubert, Bernard ^a   Ailleres, Norbert ^a   Fenoglietto, Pascal ^a   Dubois, Jean Bernard ^a  

^a CENTRE VAL D AURELLE   (France)

Author keywords

Breast cancer; IORT; Quality of life; Radiation boost

Indexed keywords

BREAST CANCER; BREAST CONSERVING SURGERY; COSMESIS; EARLY-STAGE BREAST CANCER; IN-VIVO; INTRAOPERATIVE RADIOTHERAPY; IORT; LOCAL RECURRENCE; MONTPELLIER; OVERALL RATE; PHASE II; PRE-TREATMENT; QUALITY INDICES; QUALITY OF LIFE; SALVAGE MASTECTOMY;

DOSIMETRY; FISH; TUMORS;

RADIOTHERAPY;

AROMATASE INHIBITOR; TAMOXIFEN;

AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSIMETRY; ELECTRON; ESTHETICS; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INTRAOPERATIVE RADIOTHERAPY; LINEAR ACCELERATOR; MASTECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RECURRENT CANCER; SALVAGE THERAPY; SURVIVAL RATE; THERAPY EFFECT; TREATMENT OUTCOME; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAOPERATIVE PERIOD; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 76249099756     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.039     Document Type: Article

References (26)

1. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
2. van Dongen J.A., Voogd A.C., Fentiman I.S., et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92 (2000) 1143-1150
3. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002) 1227-1232
4. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366 (2005) 2087-2106
5. Bartelink H., Horiot J.C., Poortmans P.M., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25 (2007) 3259-3265
6. Reitsamer R., Sedlmayer F., Kopp M., et al. Concepts and techniques of intraoperative radiotherapy (IORT) for breast cancer. Breast Cancer 15 (2008) 40-46
7. Dubois J.B., Hay M., Gely S., et al. IORT in breast carcinomas. Front Radiat Ther Oncol 31 (1997) 131-137
8. Reitsamer R., Peintinger F., Kopp M., et al. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study. Strahlenther Onkol 180 (2004) 38-44
9. Lemanski C., Azria D., Thezenas S., et al. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results. Int J Radiat Oncol Biol Phys 64 (2006) 1410-1415
10. Singletary S.E., Allred C., Ashley P., et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20 (2002) 3628-3636
11. Gatzemeier W., Orecchia R., Gatti G., et al. Intraoperative radiotherapy (IORT) in treatment of breast carcinoma: A new therapeutic alternative within the scope of breast-saving therapy? Current status and future prospects. Report of experiences from the European Institute of Oncology (EIO), Mailand. Strahlenther Onkol 177 (2001) 330-337
12. Trotti A., Colevas A.D., Setser A., et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 (2003) 176-181
13. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
14. Osoba D., Aaronson N., Zee B., et al. Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer. The Study Group on Quality of Life of the EORTC and the Symptom Control and Quality of Life Committees of the NCI of Canada Clinical Trials Group. Qual Life Res 6 (1997) 103-108
15. Katz S., and Akpom C.A. A measure of primary sociobiological functions. Int J Health Serv 6 (1976) 493-508
16. Katz S., and Akpom C.A. 12. Index of ADL. Med Care 14 (1976) 116-118
17. Lawton M.P., and Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9 (1969) 179-186
18. Fisher B., Bryant J., Dignam J.J., et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20 (2002) 4141-4149
19. Hughes K.S., Schnaper L.A., Berry D., et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351 (2004) 971-977
20. Veronesi U., Marubini E., Mariani L., et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12 (2001) 997-1003
21. Smith T.E., Lee D., Turner B.C., et al. True recurrence vs. new primary ipsilateral breast tumor relapse: An analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 48 (2000) 1281-1289
22. Holland R., Veling S.H., Mravunac M., et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 56 (1985) 979-990
23. Orecchia R., Ciocca M., Tosi G., et al. Intraoperative electron beam radiotherapy (ELIOT) to the breast: A need for a quality assurance programme. Breast 14 (2005) 541-546
24. Olson T.P., Harter J., Munoz A., et al. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence. Ann Surg Oncol 14 (2007) 2953-2960
25. Gruenberger T., Gorlitzer M., Soliman T., et al. It is possible to omit postoperative irradiation in a highly selected group of elderly breast cancer patients. Breast Cancer Res Treat 50 (1998) 37-46
26. Mandelblatt J.S., Hadley J., Kerner J.F., et al. Patterns of breast carcinoma treatment in older women: Patient preference and clinical and physical influences. Cancer 89 (2000) 561-573